█ INTRODUCTION
S pinal cord injury (SCI) is a catastrophic, multistep cascade that causes various symptoms and morbidities. It was first defined in the ancient Egyptian Edwin Smith Papyrus from 2500 BC (16) and was thought to be untreatable with mortality rates reaching up to 80% until the 20 th century (9) . Developments in imaging, surgery, medicine, and rehabilitation contributed to a considerable improvement in SCI management. Neuroprotection and neuroregeneration are subjects of intense interest given the inevitability of the primary injury caused by trauma (21) . trauma or injury (10) . It was first discovered in Japan in 1939 (25) , and has become popular and even labeled as the "miraculous molecule" at the beginning of the 21 st century. Leading pharmaceutical brands have focused on the molecule; numerous studies have investigated its effects on cancer (4,6), Alzheimer's disease (26) , heart diseases (24), diabetes (15) , and depression (22) . Subsequently, resveratrol has become popular along with red wine as it contains the highest level of trans-resveratrol (23) .
Resveratrol diminishes the oxidation of low-density lipoproteins by chelating copper and phagocytosis of oxygen-free radicals. Furthermore, it disrupts platelet aggregation formation, thereby decreasing the rate of thrombus formation. It alters arachidonic acid metabolism and inhibits protein kinase activities, thereby proving its anti-inflammatory, anti-bacterial, and anti-apoptotic effects (27) .
Numerous studies on resveratrol have focused on its effects after SCI (7, 13, 14, 17, 20, 27, 29) . These studies have targeted resveratrol's effects on oxidative stress, anti-inflammatory process, and apoptosis. During the subacute phase of SCI, rapid and extreme oxidative stress causes necrosis of neurons, leading to diminished blood flow followed by an inflammatory response. In addition, apoptosis worsens the primary injury by obliterating neurons, oligodendrocytes, microglia, and astrocytes (29) . Thus, the present study focuses on resveratrol's effects on tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and motor neuron, glial cell, and apoptotic cell counts after experimental spinal trauma on rats.
█ MATERIAL and METHODS
The experimental procedures on the subjects were performed at the TICAM Experimental Animals Laboratory of Osmangazi University School of Medicine. Tissue preparation for histological analysis was carried out at the Department of Pathology, Hitit University, and immunohistochemical analysis was performed at the Department of Pharmacology, Osmangazi University. The experiment was approved by the Experimental Animals Ethical Committee of Osmangazi University (384/2014).
A total of 18 female Sprague-Dawley rats weighing 200-250 g were used. They were divided randomly and equally into three groups: control, trauma, and resveratrol. The animal subjects received 60 mg/kg of ketamine hydrochloride intraperitoneally (IP) (Alfamine 10%, Egevet Veterinary Services, Turkey) and 5 mg/kg of xylazin (Alfazyne 2%, Egevet Veterinary Services, Turkey) for general anesthesia under the control of a veterinary physician.
Experimental Procedure
Animals were fixed in the prone position on a board. A midline incision at about the T9 level was performed. After the T8-10 laminectomy, the spinal cord was exposed. The spinal cord of the control group did not undergo any further intervention. The spinal cord of those in the trauma and resveratrol groups was compressed using the aneurysm clip compression technique for 60 seconds; described first by Dolan in 1979 (8) . Yasargil's aneurysm clip (FE 740 K) with a closing pressure of 1.43 N was used. The resveratrol group received 10 mg/kg of resveratrol IP after the trauma. At the end of the experiment, the animal subjects were given standard bait and free access to tap water and kept in separate cages at 22°C. The bladders were manually emptied, and bait was kept close to the rats as they were all paraplegic. They were euthanized after 24 hours under the same anesthesia through decapitation, and sections of the vertebral colon from T7 to T11 were removed for further analysis.
Enzyme-Linked Immunosorbent Assay (ELISA)
Blood was drawn from the animal subjects before euthanasia to measure inflammatory cytokines released in response to trauma. Blood samples were analyzed for TNF-α and IL-1β levels at the Department of Pharmacology, Osmangazi University, via ELISA (eBioscience, Bender MedSystems, Vienna, Austria).
Histological Analysis
All tissue samples were fixed for 24 hours in 10% formaldehyde at the Department of Pathology, Hitit University. Tissue samples were embedded in paraffin, and 5-μm slices were obtained. These sections were stained using hematoxylineosin (H&E), glial fibrillary acidic protein (GFAP), and terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) methods.
A light microscope (Nikon E200) under 5× magnification field (×400) was used; neurons and glial cells were counted under each magnification field. GFAP antibody (Biogen) was used via an automated immunohistochemistry stainer (Ventana). GFAP staining allows visualization of GFAP to confirm the presence of glial cells that increase in number secondary to trauma or malignancy (11) . The TUNEL method allows the labeling of deoxyribonucleic acid (DNA) of cells that are undergoing apoptosis by binding TdT to DNA fragments, which are labeled with a marker. The number of apoptotic cells was counted under light microscope (Nikon E200, ×400). Analysis was carried out using computer software by pathologists blinded to the experiment.
Statistical Analysis
Sigmastat 3.5 (Sysstat Software Inc.) and IBM SPSS Statistics for Windows 21.0 (IBM Corp) were used to analyze the data. Descriptive statistics were presented as mean ± standard deviation. Given that the comparison of TNF-α and IL-1β levels yielded a normal distribution, one-way analysis of variance (ANOVA) was performed. Tukey's test was used for multiple comparison tests. Cell counts were compared by using Mann-Whitney U test.
Cell counts were compared using Mann-Whitney U test via IBM SPSS Statistics for Windows 16 .0 to analyze the data obtained from histological analysis.
█ RESULTS
Biochemical Findings
TNF-α and IL-1β levels in all groups were measured to evaluate the extent of immune response and correlated apoptosis. The resveratrol group had statistically significant lower level of cytokines than the trauma group.
Comparison results showed that the TNF-α means of the trauma group (684.167) is higher and statistically significant than those of the control (45.500) and resveratrol groups (194.167) (p<0.001). However, no statistically significant results were found between the TNF-α means of the resveratrol and control groups (p=0.110) ( Tables I, II) .
Comparison results showed that the IL-1β means of the trauma group (791.667) are higher and statistically significant than those of the control (29.167) and resveratrol groups (137.500) (p<0.001). However, no statistically significant results were found between the IL-1β means of the resveratrol and control groups (p=0.027) (Tables III, IV) .
Histopathological Findings
Histological analyses of all animal subjects concerning motor neuron, glial cell, and apoptotic cell counts were performed. The resveratrol group had a statistically higher count of motor neuron and glial cells, but no TUNEL positive-stained cells. The results obtained from this study sheds novel insights into the pathology and potential treatment of SCI. This study supports resveratrol's anti-inflammatory and anti-apoptotic effects through biochemical and immunohistochemical analyses. Resveratrol had a great effect on reducing proinflammatory cytokines TNF-α and IL-1β, and the effects were visualized through histological examination, which showed increased glial and motor neuron cell counts with decreased apoptosis compared with the trauma group.
Resveratrol diminishes the oxidation of low-density lipoproteins by eliminating oxygen-free radicals. It proves to have anti-inflammatory, anti-bacterial, and anti-apoptotic effects by altering arachidonic acid metabolism and inhibiting protein kinase activities (27) . Moreover, a previous study has reported this effect along with alleviating hemorrhage and edema in neural tissue while also reversing tissue necrosis and apoptosis (29) . In addition, another report revealed resveratrol's effect of partially restoring normal functions in neurons, most
When the motor neuron cells in the trauma group (4.06) were compared with those of the control (13.05) and resveratrol (9.05) groups, the results were statistically significant (p= 0.001 and 0.006). However, when the control and resveratrol groups were compared, no statistically significant difference was found (p=0.472). Resveratrol protected the number of motor neuron cells significantly than the trauma group ( Figure 1A-D) .
When the glial cells in the trauma group (4.5) were compared with the control (13.5) and resveratrol (8.5) groups, the results were statistically significant (p=0.000 and 0.02). Moreover, the number of glial cells in the resveratrol group was lower and statistically significant than the control group (8.5 vs. 13.5) (p=0.02) (Figure 2A-C) .
TUNEL-positive-stained apoptotic cells were observed mainly in the trauma group, whereas the control and resveratrol groups did not show any significant positive staining ( Figure  3A -D). Higher doses of resveratrol (100 mg/kg IP) have shown promising anti-inflammatory effects by reducing malondialdehyde (MDA). The same study revealed that with an even higher dose (200 mg/kg IP), the antioxidant effects become more apparent by reducing xanthine oxidase and nitric oxide levels while increasing superoxide dismutase (SOD) activity and glutathione peroxidase (GSH) levels (3).
In the present experimental study on 18 rats, three randomized groups were used to evaluate the effects of resveratrol on spinal cord trauma. Biochemical analysis was performed to measure the levels of TNF-α and IL-1β, which have been increased after spinal trauma and majorly constituted the secondary phase of SCI, such as inflammation (1). The TNF-α means of the trauma group (684.167) was statistically higher than the resveratrol group (194.167) (p< 0.001). Resveratrol has been previously shown to reduce inflammation by decreasing TNF-α-induced activation of mitogen-activated protein kinases and nuclear factors that eventually reduced expression of intercellular adhesion molecule 1 (ICAM-1) and adhesion of monocytes (18) . The biochemical parameters obtained in the present study in parallel with the recent literature has shown resveratrol's anti-inflammatory effects on spinal cord after trauma, which may prove to be beneficial in reducing the damage caused by the secondary phase of SCI.
A pilot study conducted on 23 patients with SCI revealed that both TNF-α and IL-1β levels were correlated with recovery status as patients with better overall outcome had lower levels of both cytokines (5). This is the reason that the present study focused only on these two cytokines. The results obtained in the present study also reported a statistically significant (p<0.001) lower value of IL-1β in the resveratrol group (137.500) than the control group (791.667). Another study that has focused on inflammation and apoptosis after SCI has stressed the importance of upregulated cytokines beginning as early as 30 minutes after the initial trauma starts an inflammatory cascade that develops exponentially, leading to the destruction of the remaining healthy neural tissues (28) . Thus, several studies have focused on reducing the overexpressed inflammation after SCI, and the present study support resveratrol's effects on reducing both inflammation and apoptosis. A recent comprehensive paper proposed two different treatment modalities to evaluate the effects of resveratrol on traumatic brain injury on rats. Low-and highdose treatments were given daily (50 and 100 mg/kg per day). Multiple biochemical analyses were performed to measure MDA, SOD, GSH, and 8-OHdG/106 dG (oxidative DNA damage) levels. All parameters were found to be higher in the trauma group, suggesting the protective and possible healing effect of resveratrol after traumatic brain injury. No statistically significant difference was found between the high-and lowdose treatments, suggesting that resveratrol may prove beneficial even at low doses (2) . The results obtained from the present study proved the beneficial results of resveratrol even at 10 mg/kg dose. 
A B C
to the present study, TUNEL staining was obtained along with H&E, NeuN analysis, and Western Blot to determine Bcl-2, Bax, and caspase-3 levels. The rats received 30 mg/kg IP of resveratrol similar to the present study but were given treatment consecutively for 7 days before the procedure (19) . This crucial study supports resveratrol's neuroprotective effects by inhibiting neuronal apoptosis. In addition, the administration of resveratrol before the procedure may prove its prophylactic effect on cerebral ischemia.
The present experimental study provides support for the antiapoptotic mechanisms of resveratrol through histological analysis. The resveratrol group had no TUNEL-positive stains, whereas the trauma group had positive stains displaying cells that were undergoing apoptosis. In addition, H&E and GFAP staining showed that compared with the trauma group's motor neuron cell (4.06) and glial cell (4.5) counts, the treatment groups had a better outcome with 9.05 and 8.50, respectively. Both comparisons yielded a statistically significant result (p=0.001).
The TUNEL staining method allows the labeling of DNA of cells that are undergoing apoptosis by binding TdT to DNA fragments that are labeled with a marker. In a study using electron microscope identification and TUNEL staining, the resveratrol group showed a statistically significant decreased number of TUNEL-positive cells. Moreover, the resveratrol group showed the effects of improving abnormal cellular morphology by the inhibition or reduction in neuronal shrinkage, disappearance of mitochondrial ridges, cytoplasm vacuolization, and enlargement of the endoplasmic reticulum, which all contribute to a cell's path toward apoptosis (17) .
Resveratrol has also been shown to inhibit the upregulation of pro-apoptotic factor Bax and terminal executing enzymes for substrate cleavage of caspase-3. Moreover, the downregulation of anti-apoptotic factor Bcl-2 after SCI was inhibited (17) . Another study reported that resveratrol could prevent apoptosis in neurons by activating the PI3K/Akt pathway (30) . These effects can be contributed to the anti-apoptotic effect of resveratrol. A larger series of subjects evaluated resveratrol's effects on transient cerebral ischemia in 60 rats; similar A B C D
